Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,087,917
+$1,868,660 QoQ
Shares Held
572,287
+7.1% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#127
of 1,020 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $92,574,463 across 16 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
175,685 | $29,609,949 | |
| 2 | ZTS |
Zoetis Inc.
|
268,075 | $19,263,869 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
2,367,493 | $9,967,145 | |
| 4 | VTRS |
Viatris Inc
This page
|
572,287 | $9,087,917 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
15,849 | $8,587,463 | |
| 6 | CRON |
Cronos Group Inc.
|
1,597,039 | $4,439,768 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
347,299 | $3,472,990 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
91,604 | $3,103,543 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,087,917 | 572,287 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,219,257 | 534,364 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,122,765 | 652,431 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $8,641,294 | 872,858 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $12,355,181 | 1,383,559 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,944,354 | 338,043 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,593,135 | 208,284 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $6,008,233 | 517,505 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $20,512,774 | 1,929,706 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $21,031,724 | 1,761,451 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $22,315,507 | 2,060,527 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $20,345,025 | 2,063,390 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $8,907,259 | 892,511 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $4,267,672 | 443,625 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $3,040,181 | 273,152 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,033,459 | 238,669 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $2,319,345 | 221,523 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $2,395,721 | 220,195 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,328,715 | 172,115 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,310,058 | 170,484 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,241,643 | 156,868 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,446,915 | 246,737 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,789,981 | 255,602 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||